Benefits of Respiration-Gated Radiotherapy for Lung Cancer
Author Information
Author(s): Underberg René WM, van Sörnsen de Koste John R, Lagerwaard Frank J, Vincent Andrew, Slotman Ben J, Senan Suresh
Primary Institution: VU University medical center
Hypothesis
Can respiration-gated radiotherapy reduce the risk of pulmonary toxicity in patients with stage III lung cancer?
Conclusion
Respiration-gated radiotherapy can reduce the risk of pulmonary toxicity, especially for tumors located in the middle and lower lobes.
Supporting Evidence
- Smaller planning target volumes were derived using patient-specific mobility data.
- Reductions in mean lung dose were observed with respiration-gated radiotherapy.
- Dosimetric gains were smaller for primary tumors of the upper lobe compared to other locations.
Takeaway
This study shows that using special techniques to target lung tumors during breathing can help protect healthy lung tissue from radiation damage.
Methodology
The study analyzed 4DCT scans of 15 patients to compare different treatment planning volumes and their effects on lung toxicity.
Limitations
The esophagus was only contoured in one phase of respiration, which may affect the conclusions about dosimetric impact.
Participant Demographics
Patients had stage III non-small cell lung cancer with primary tumors located in the upper, middle, and lower lobes.
Statistical Information
P-Value
p < 0.001
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website